| 1 |
Umbilical cord blood amino-terminal pro-brain natriuretic peptide levels according to the mode of delivery |
|
|
| Seong, W.J., Yoon, D.H., Chong, G.O., Hong, D.G., Koo, T.B., Lee, T.H., Chun, S.S. |
|
| Archives of Gynecology and Obstetrics. 2010; 281(5): 907-912 |
|
| [Pubmed] [Google Scholar] |
|
| 2 |
Cardiovascular and renal surrogate markers in the clinical management of hypertension |
|
|
| Maisel, A.S. |
|
| Cardiovascular Drugs and Therapy. 2009; 23(4): 317-326 |
|
| [Pubmed] [Google Scholar] |
|
| 3 |
Voluntary exercise-induced changes in beta(2)-adrenoceptor signalling in rat ventricular myocytes |
|
|
| Stones R, Natali A, Billeter R, et al. |
|
| EXPERIMENTAL PHYSIOLOGY. 2008; 93(9): 1065-1075 |
|
| [Pubmed] [Google Scholar] |
|
| 4 |
Significantly raised brain natriuretic peptide in a young patient with dengue fever without heart and renal failure |
|
|
| Sule, A.A., Tai, D.Y.H., Yue, K.N., Chadachan, V., Ng, K. |
|
| Critical Care and Shock. 2007; 10(3): 111-114 |
|
| [Pubmed] [Google Scholar] |
|
| 5 |
1.8 {A figure is presented} Laboratory and Diagnostic Testing: A Perioperative Update |
|
|
| Pagana, K.D. |
|
| AORN Journal. 2007; 85(4): 754-762 |
|
| [Pubmed] [Google Scholar] |
|
| 6 |
The stealth factor in cardiovascular disease risk |
|
|
| Agruss, J.C., Garrett, K. |
|
| Nursing Made Incredibly Easy. 2006; 4(2): 51-55 |
|
| [Pubmed] [Google Scholar] |
|
| 7 |
Performance characteristics of four automated natriuretic peptide assays |
|
|
| Rawlins ML, Owen WE, Roberts WL |
|
| AMERICAN JOURNAL OF CLINICAL PATHOLOGY. 2005; 123 (3): 439-445 |
|
| [Pubmed] [Google Scholar] |
|
| 8 |
Blood B-type natriuretic peptide changes in different periods and different cardiac pacing modes |
|
|
| Wang RX, Li XR, Jang WP, et al. |
|
| INTERNATIONAL HEART JOURNAL. 2005; 46 (6): 1015-1022 |
|
| [Pubmed] [Google Scholar] |
|
| 9 |
Dysfunction of atrial and B-type natriuretic peptides in congenital univentricular defects |
|
|
| Sun LS, Dominguez C, Mallavaram NA, Quaegebeur JM |
|
| JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY. 2005; 129(5): 1104-1110 |
|
| [Pubmed] [Google Scholar] |
|
| 10 |
New pharmacologic approaches for the perioperative treatment of ischemic cardiogenic shock |
|
|
| Lehmann, A., Boldt, J. |
|
| Journal of Cardiothoracic and Vascular Anesthesia. 2005; 19(1): 97-108 |
|
| [Pubmed] [Google Scholar] |
|
| 11 |
Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling |
|
|
| Zhang QH, Moalem J, Tse J, et al. |
|
| EUROPEAN JOURNAL OF PHARMACOLOGY. 2005; 510 (3): 209-215 |
|
| [Pubmed] [Google Scholar] |
|
| 12 |
Genetic expression profiles during physiological and pathological cardiac hypertrophy and heart failure in rats |
|
|
| Kong SW, Bodyak N, Yue P, Liu Z, Brown J, Izumo S, Kang PM |
|
| PHYSIOLOGICAL GENOMICS. 2005; 21 (1): 34-42 |
|
| [Pubmed] [Google Scholar] |
|
| 13 |
Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance |
|
|
| Abassi Z, Karram T, Ellaham S, Winaver J, Hoffman A |
|
| Pharmacology & Therapeutics. 2004; 102(3): 223-241 |
|
| [Pubmed] [Google Scholar] |
|
